Advanced pelvic paraganglioma presenting as hematuria and urinary retention with a large intravesical mass: A case report.

Thomas Syphan, Heloisa Soares, Jessica F Williams, Alejandro Sanchez, Christopher Dechet

Abstract readCase Reports

In one paragraph

Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas SyphanCase Western Reserve University School of Medicine, Cleveland, OH, USA.

Heloisa SoaresDivision of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Jessica F WilliamsDepartment of Pathology, Spencer Fox Eccles School of Medicine, University of Utah, and ARUP Laboratories, Salt Lake City, UT, USA.

Alejandro SanchezDivision of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Christopher DechetDivision of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas are neuroendocrine tumors arising from extra-adrenal chromaffin cells within the autonomic nervous system. Primary urogenital disease is rare (6.7% of paragangliomas), with prostatic involvement reported in only a few case studies. Management follows National Comprehensive Cancer Network (NCCN) guidelines for neuroendocrine and adrenal tumors; however, there is limited data to guide systemic therapy in cases that present with metastasis. We describe a report of a 60-year-old man with metastatic pelvic paraganglioma detected after 4 months of gross hematuria and urinary retention. Despite the large tumor burden, the patient has been successfully treated with systemic therapy after an appropriate workup.

Indexed as

Germline testingNeuroendocrine tumorsParagangliomaProstatic neoplasmSystemic therapy

Identifiers

PMID42394965

DOI10.1016/j.eucr.2026.103522

PMCPMC13324296

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.